Q-Switched Neodymium: Yttrium-Aluminum-Garnet Laser Treatment of Lentigo Maligna

Abstract

Lentigo maligna is a premalignant lesion of atypical melanocytes that typically arises on the head and neck of elderly patients. It is considered a melanoma in situ with a significant risk for transformation to invasive lentigo maligna melanoma. Surgery is the preferred method of treatment; however, because of the advanced age of the typical patient with lentigo maligna, the frequency of complicating medical problems, and the cosmetic or functional aspects of treatment, surgical excision is not always feasible. The purpose of this pilot study was to evaluate the efficacy and safety of Q-switched neodymium:yttrium-aluminum-garnet laser treatment of lentigo maligna. Eight patients were treated with 532 and/or 1064 nm wavelengths from the laser. All patients showed a response to laser therapy, and 2 patients treated with 1 treatment from each wavelength had complete eradication of the LM, with no evidence of recurrence in 42 months. Further study is warranted, but Q-switched neodymium:yttrium-aluminum-garnet laser is a promising alternative treatment for lentigo maligna.

Get full access to this article

View all access options for this article.

References

Hutchinson

. Senile freckles. Arch Surg 1892;3:319.

Clark

Jr From

Bernadino

et al. The histiogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 1969;29:705–27.

Weinstock

Sober

. The risk of progression of lentigo maligna melanoma. Br J Dermatol 1987;116:303–10.

Wayte

Helwig

. Melanotic freckle of Hutchinson. Cancer 1968;21:893–911.

Anderson

Margolis

Watanabe

et al. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol 1989;93:28–32.

Pitman

Hopf

Bart

et al. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol 1979;5:727–37.

Cramer

Kiehn

. Sequential histologic study of evolving lentigo maligna melanoma. Arch Pathol Lab Med 1982;106:121–5.

Zacarian

. Cryosurgical treatment of lentigo maligna. Arch Dermatol 1982;118:89–92.

Kuflik

Gage

. Cryosurgery for lentigo maligna. J Am Acad Dermatol 1994;31:75–8.

10.

Lindo

Daniels

. Cryosurgery of the junctional nevi. Cutis 1975;16:492–6.

11.

Miescher

. Ueber melanotische pre cancerose. Oncologic 1975;7:92–4.

12.

Stork

. Treatment of melanotic freckles by radiotherapy. J Dermatol Surg Oncol 1977;3:282–5.

13.

Kopf

Bart

Gladstein

. Treatment of melanotic freckle with x-rays. Arch Dermatol 1976;112:801–7.

14.

Harwood

. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1982;6:310–6.

15.

Murphy

Shepard

Paul

et al. Organelle-specific injury to melanin containing cells in human skin by pulsed laser irradiation. Lab Invest 1983;49:680–5.

16.

Ohshiro

Maruyama

. The ruby and argon lasers in the treatment of naevi. Ann Acad Med Singapore 1983;12:388–95.

17.

Grekin

Shelton

Geisse

et al. 510 nm pigmented lesion dye laser. J Dermatol Surg Oncol 1993;19:380–7.

18.

Dinehart

Waner

Flock

. The copper vapor laser for the treatment of cutaneous vascular and pigmented lesions. J Dermatol Surg Oncol 1993;19:28–32.

19.

Goldberg

. Benign pigmented lesions of the skin: Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol 1993;19:376–9.

20.

Goldman

Rockwell

Meyer

et al. Laser treatment of tattoos: A preliminary survey of three years' clinical experience. JAMA 1967;201:841–4.

21.

Fitzpatrick

Goldman

Ruiz-Esparza

. Laser treatment of benign pigmented epidermal lesion using a 300 nanosecond pulse and 510 nm wavelength. J Dermatol Surg Oncol 1993;19:341–7.

22.

Goldberg

Nychay

. Q-switched ruby laser treatment of nevus of Ota. J Dermatol Surg Oncol 1984;953–7.

23.

Arndt

. New pigmented macule appearing four years after argon laser treatment of lentigo maligna. J Am Acad Dermatol 1986;14:1092.

24.

Kauvar

ANB

Geronemus

. Treatment of lentigo maligna with the Q-switched ruby laser [abstract]. Lasers Surg Med 1995; (suppl 7):48.

25.

Robinson

. Margin control for lentigo maligna. J Am Acad Dermatol 1994;31:79–85.

26.

Kilmer

Anderson

. Clinical use of the Q-switched ruby and the Q-switched Nd: YAG (1064 nm and 532 nm) lasers for the treatment of tattoos. J Dermatol Surg Oncol 1993;19:330–8.